Moderna to Provide up to 125 Million COVID-19 Vaccine Doses Globally in Early 2021

Only 18% of Moderna COVID Vaccine Trial Participants are Latino, Black, Indigenous People

Biotech Moderna said on Friday that Latino, Black and Indigenous people only made up 18% of their phase three vaccine trials participants.
FDA Scientists Endorse Moderna's COVID-19 Vaccine for Emergency Use

US, Moderna Ink $1.5 Billion Deal on COVID-19 Vaccines

By Dana Cruz
The United States has entered an agreement with drugmaker Moderna for 100 million doses of potential COVID-19 vaccines worth around $1.5 billion, both the company and White House announced on Tuesday.
COVID-19 Vaccine, Coronavirus Vaccine

Will a COVID-19 Vaccine be Ready Before the End of 2020? Here's What Experts Say

By Dani O.
There are currently 36 vaccine candidates in pre-clinical studies or clinical trials across the globe, with 2 major companies in the lead.
Scientists develop a vaccine against the coronavirus disease in Saint Petersburg

Moderna to Start Final Phase of COVID-19 Vaccine Trial. How Safe Is It?

By Dani O.
The third and final phase of the trial will involve over 30,000 participants and is expected to begin in July.
Most Read
  1. Tini Stoessel & Young Miko Aren't Hiding Anymore
  2. First Photos of Gisele Bündchen’s Baby Bump: A Cover-Worthy Mom-to-Be!
  3. The Best Places to Celebrate Halloween in the United States
  4. Tekashi 6ix9ine is Back in the Spotlight After Being Arrested Again—Will He Lose His Record Deal?
Real Time Analytics